1 analysts on average are expecting CytRx Corporation to report earnings of $-0.5 per share for the current quarter.
Headlines about CytRx (NASDAQ:CYTR) have been trending somewhat positive on Thursday, Alpha One reports. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. The average analysts gave this company a mean recommendation of 2.00.
The counter witnessed a trading volume of 0.46 million shares versus an average volume of 0.48 million shares during last trading session.
The stock volatility for week was 7.63% while for month was 13.66%.The stock, as of last close, traded 16.81% to its 52 week low and was changed -87.18% from its 52 week high. The stock presently has an average rating of Buy and an average target price of $1.80. The stock's price is floating in a range of $4.73 and $4.95 whereas, it's 52-week High Price is $5.53 with respect to its 52-week Low Price of $3.74.
CytRx Corporation had its "outperform" rating reiterated by analysts at FBR Capital Markets.
Shares of CytRx Corporation (NASDAQ:CYTR) fell $-0.01 during today's regular trading session, a -2.91% decrease from the previous closing price of $0.43.
Four-goal Kane helps Spurs punish Leicester
Eight minutes later Son struck again, ridiculing Wilfred Ndidi at the edge of the box before sweeping a low shot into the net. But Pochettino insists Tottenham are not in a position to sell any player who they see as important to the squad.
CytRx Corporation announced its recent quarter financial results after the market close on 01/01/1970, crushing consensus estimates with both its revenue and earnings.
Maximum and minimum EPS estimate for the current quarter is projected at $-0.5 and $-0.5, respectively, according to 1 analysts.
In the quarter ending March 2016, CytRx Corporation delivered smaller earnings beat. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. CytRx Corporation has a 52-week low of 0.36 and a 52-week high of 3.28. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.
Currently Cytrx Cp (NASDAQ:CYTR)'s shares owned by insiders are 1.7%, whereas shares owned by institutional owners are 17.5%. The stock has a 50 day moving average price of $0.50 and a 200 day moving average price of $0.46. The recommendation scale measures the value from 1 to 5, where 1 means "Strong Buy" and 5 stands for "Sell".
CytRx Corporation has a consensus outperform rating from 1 Wall Street analysts, and the number of shares now sold short amount to at least 18.64% of shares outstanding. The ROA ratio is calculated by comparing net income to average total assets, and is expressed as a percentage.
Pillar hits winning homer in 9th, Jays beat Mariners 3-2
Danny Barnes then replaced the Toronto southpaw and put runners on the corners before fanning former Blue Jay Danny Valencia. And neither are these Blue Jays , the recent sad sacks of baseball, who are making others take notice of their success .
Browns sign Texas A&M's Myles Garrett, 1st overall pick
The defensive end was a three-year starter at Texas A&M, where he had 31 sacks, 141 tackles and seven forced fumbles. The mysterious lyrics to " Kiss from a Rose " only add to the mystery of why it was Garrett's choice.
Duke Energy Corp's (NYSE:DUK) Sentiment is 1.1
On average, equities analysts anticipate that Duke Energy Corp will post $4.61 earnings per share for the current fiscal year. ILLEGAL ACTIVITY WARNING: This article was first reported by Transcript Daily and is owned by of Transcript Daily.